Maturity-onset diabetes of the balanced translocation where results in disruption upstream young caused by a the 20q12 break point of the coding region of hepatocyte nuclear factor-4α (HNF4A) gene

被引:27
作者
Gloyn, AL
Ellard, S
Shepherd, M
Howell, RT
Parry, EM
Jefferson, A
Levy, ER
Hattersley, AT
机构
[1] Univ Exeter, Dept Diabet & Vasc Med, Exeter, Devon, England
[2] Southmead Gen Hosp, Reg Cytogenet Ctr, Bristol, Avon, England
[3] Univ Coll Swansea, Sch Biol Sci, Swansea, W Glam, Wales
[4] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England
关键词
D O I
10.2337/diabetes.51.7.2329
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monogenic human disorders have been used as paradigms for complex genetic disease and as tools for establishing important insights into mechanisms of gene regulation and transcriptional control. Maturity-onset diabetes of the young (MODY) is a monogenic dominantly inherited form of diabetes that is characterized by defective insulin secretion from the pancreatic beta-cells. A wide variety of mutation types in five different genes have been identified that result in this condition. There have been no reports of a chromosome deletion or translocation resulting in MODY. We report a pedigree where MODY cosegregates with a balanced translocation [karyotype 46, XX t(3;20) (p21.2;q12)]. The chromosome 20 break point, 20q12, is within the region of one of the known MODY genes, hepatocyte nuclear factor-4alpha (HNF4A). Fluorescence in situ hybridization analysis demonstrated that the break point does not disrupt the coding region of this gene, but it lies at least 6 kb upstream of the conventional promoter (P1). We propose that this mutation disrupts the spatial relationship between the recently described alternate distal pancreatic promoter (P2) and HNF4A. This is the first case of MODY due to a balanced translocation, and it provides evidence to confirm the crucial role of an upstream regulator of HNF4A gene expression in the beta-cell.
引用
收藏
页码:2329 / 2333
页数:5
相关论文
共 21 条
  • [1] An enhancer element 6 kb upstream of the mouse HNF4α1 promoter is activated by glucocorticoids and liver-enriched transcription factors
    Bailly, A
    Torres-Padilla, ME
    Tinel, AP
    Weiss, MC
    [J]. NUCLEIC ACIDS RESEARCH, 2001, 29 (17) : 3495 - 3505
  • [2] A transcription factor regulatory circuit in differentiated pancreatic cells
    Boj, SF
    Párrizas, M
    Maestro, MA
    Ferrer, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) : 14481 - 14486
  • [3] Ellard S, 2000, HUM MUTAT, V16, P377, DOI 10.1002/1098-1004(200011)16:5<377::AID-HUMU1>3.0.CO
  • [4] 2-2
  • [5] Fajans SS, 1996, DIABETIC MED, V13, pS90
  • [6] LADIAS JAA, 1992, J BIOL CHEM, V267, P15849
  • [7] A forkhead-domain gene is mutated in a severe speech and language disorder
    Lai, CSL
    Fisher, SE
    Hurst, JA
    Vargha-Khadem, F
    Monaco, AP
    [J]. NATURE, 2001, 413 (6855) : 519 - 523
  • [8] Mutation in the HNF-4α gene affects insulin secretion and triglyceride metabolism
    Lehto, M
    Bitzén, PO
    Isomaa, B
    Wipemo, C
    Wessman, Y
    Forsblom, C
    Tuomi, T
    Taskinen, MR
    Groop, L
    [J]. DIABETES, 1999, 48 (02) : 423 - 425
  • [9] A patient with maternal chromosome 14 UPD presenting with a mild phenotype and MODY
    Manzoni, MF
    Pramparo, T
    Stroppolo, A
    Chiaino, F
    Bosi, E
    Zuffardi, O
    Carrozzo, R
    [J]. CLINICAL GENETICS, 2000, 57 (05) : 406 - 408
  • [10] HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN
    MATTHEWS, DR
    HOSKER, JP
    RUDENSKI, AS
    NAYLOR, BA
    TREACHER, DF
    TURNER, RC
    [J]. DIABETOLOGIA, 1985, 28 (07) : 412 - 419